Peetz Christopher sold MIRM
August 11, 2025 · Form 4 insider transaction
Peetz Christopher sold 40,000 shares of Mirum Pharmaceuticals, Inc. at $62.00 per share, a transaction worth $2.48M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
40,000
Price
$62.00
Total value
$2.48M
InsiderPeetz Christopher
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 11, 2025
Filing dateAugust 12, 2025
Shares owned after138,641
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on November 22, 2024.